Search results
Weight loss drugs such as Ozempic, Wegovy could spell trouble for the diet industry
New York Post· 7 days agoMorgan Stanley research...founded in 1963, last year acquired telehealth provider Sequence, enabling...
DOJ plans to reschedule marijuana as a lower-risk drug
WKBT La Crosse· 2 days agoThe US Department of Justice is expected to recommend that marijuana be rescheduled as a Schedule...
DEA plans to reschedule marijuana as a lower-risk drug
ABC12 Mid-Michigan· 2 days agoThe Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a...
DEA looks to reclassify marijunana as less dangerous drug. What does that mean for the DMV?
WTTG via Yahoo News· 21 hours ago"Now it's kind of limited to shops they have and stuff like that." Mister tells FOX 5 that he currently pays for a Maryland medical marijuana card. Also, the DEA publishing the final reclassification ...
CVS’s stock suffers biggest drop in 15 years as Medicare Advantage issues weigh on results
Market Watch· 1 day agoCVS was also feeling “the unfavorable impact” of the drop in its Medicare Advantage star rating,...
DOJ plans to move to reschedule marijuana as a lower-risk drug - Boston News, Weather, Sports | WHDH...
7 News Boston· 2 days agoThe US Department of Justice is expected to recommend that marijuana be rescheduled as a Schedule...
Yervoy cost 2024: Coupons and more
Medical News Today· 1 day agoYervoy (ipilimumab) is a brand-name solution for intravenous injection. It’s prescribed for certain types of cancer, including melanoma, kidney cancer,...
Mariposa County Drug Take Back Day on Saturday, April 27, 2024
Sierra Sun Times· 6 days agoMariposa County Drug Take Back Day on Saturday, April 27, 2024
DOJ plans to reschedule marijuana as a lower-risk drug
WKOW 27 Madison· 2 days agoThe US Department of Justice is expected to recommend that marijuana be rescheduled as a Schedule...
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
People Magazine· 1 hour agoNovo Nordisk is investing $6.5 billion to increase production of Ozempic and Wegovy. The...